| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 48 |
| 1 | ADALIMUMAB | 15 |
| 2 | ASPIRIN | 14 |
| 3 | INFLIXIMAB | 14 |
| 4 | METHOTREXATE SODIUM | 14 |
| 5 | ACETAMINOPHEN | 13 |
| 6 | ASPIRIN 325 MG | 13 |
| 7 | ASPIRIN 81 MG | 13 |
| 8 | METHOTREXATE | 13 |
| 9 | ALBUTEROL SULFATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 1 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 1 | 0.0049 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 11 | 0.0040 |
| 3 | PENICILLIN G | 7 | 0.0030 |
| 4 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 2 | 0.0028 |
| 5 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 6 | TAMOXIFEN CITRATE | 7 | 0.0012 |
| 7 | MEFENAMIC ACID | 2 | 0.0009 |
| 8 | PENICILLIN G SODIUM | 1 | 0.0009 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Estrogen [EPC] | 20 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 4 | Vitamin D [EPC] | 15 |
| 5 | Benzodiazepine [EPC] | 14 |
| 6 | Corticosteroid [EPC] | 13 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 8 | Vitamin C [EPC] | 12 |
| 9 | Aromatase Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 2 | 0.0006 |
| 1 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 2 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 3 | beta3-Adrenergic Agonist [EPC] | 8 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 10 | 0.0001 |
| 7 | Estrogen [EPC] | 20 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Copper-containing Intrauterine Device [EPC] | 5 | 0.0001 |